Contineum Therapeutics, Inc. Class A Common Stock
CTNM
$9.69+1.36%
At close · Nov 3, 2026
Mkt cap
$429.57M
EV/Sales
—
P/E ratio
—
FY2024 Revenue
—
EPS (H1 2026)
−$0.79
Gross Margin (FY2024)
—
Profit Margin (FY2024)
—
Beta
0.89
Div yield
—
Sector
Healthcare
What matters now, from SEC filings and analyst ratings
Takeaway
A takeaway appears here once the latest filing has been analyzed.
Latest
CTNM earnings
Analysts
RatingsSector-relative grades for valuation, growth, profitability, momentum and revisions
Form 4 trades, last 90 days
Latest SEC filings
Source: SEC EDGAR · Latest filing Nov 3, 2026
Latest stored headlines
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Latest reported CTNM revenue for 2024-12-31 was $0. Net income was -$42.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CTNM currently screens at market cap $429.6M.
Use this CTNM research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CTNM income, balance, and cash tables.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company in the Healthcare sector.
Latest cached Contineum Therapeutics, Inc. Class A Common Stock (CTNM) net income for Dec 31, 2024 was -$42.3M. Statements: https://lician.com/financials/ctnm
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) market capitalization is $429.6M on the latest cached snapshot.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) cached previous close $9.56; day range $9.54 – $9.94; volume 525,811. Session quote: https://lician.com/quote/ctnm
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) latest cached earnings event is "CTNM earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CTNM filing is 8-K · Nov 3, 2026. Filings: https://lician.com/sec/ctnm
SEC filings · latest fiscal year FY2025
—
Revenue growth year over year
10-Q results and the earnings calendar
Revenue and EPS are GAAP diluted from the 10-Q. Beat or miss compares the calendar's actual with its estimate on the same basis (adj.), or revenue with the revenue estimate.
Institutional holders from SEC 13F filings
Quant rating
MetricsHow it works2.76Hold
Lician Quant Grades · vs 548 Healthcare stocks · Nov 4, 2026
Next earnings
Thu, Mar 4Lician estimate
Time not announced · in 120 days
EPS est. —
Lician projectionEarnings
Short interest
13.3%of float
2.2 days to cover
+19.2% vs prior report
FINRA · settled Oct 15Short data
52-week range
$7.08$17.57
Price $9.69 · 44.8% below high
Low $7.08, high $17.57, last $9.69.Daily closesChart
Get alerted when CTNM confirms or moves its Mar 4 report
Free account, no card. Earnings date alerts are free for every stock on your watchlist; beat/miss results come with Pro.